|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/18 | (2013.01) | ||
| A61P 25/28 | (2018.01) |
| (11) | Patento numeris | 3402817 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17703491.5 |
| Europos patento paraiškos padavimo data | 2017-01-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/012795 |
| Data | 2017-01-10 |
| (87) | Numeris | WO 2017/123517 |
| Data | 2017-07-20 |
| (30) | Numeris | Data | Šalis |
| 201662279268 P | 2016-01-15 | US |
| (72) |
DEMATTOS, Ronald Bradley , US
LU, Jirong , US
TANG, Ying , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-N3-BETA-GLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| ANTI-N3-BETA-GLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |